Arphra/Issuer/SRZN

SRZN

Surrozen, Inc.

HealthcareBiotechnologyUSUSD

$24.95

LiveJun 01, 2026

AI Brief

Market cap

$186.56M

52w range

7.80 – 35.00

P / E

—

EPS

—

Volume

38.01K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Surrozen, Inc.’s valuation

Multiples · SRZN

Historical valuation

TTM/LTM-basis multiples with σ-banded history. Fair value below uses current denominator and FY2027 consensus.

1 year 3 years 5 years

The key_metrics_ttm loader hasn't indexed enough history for SRZN to build a Z-scored multiples view yet. Try a shorter period or check back after the next daily run.

P/E (TTM)

Not enough history to compute a Z-score for this multiple (3y · n=0).

EV / EBITDA (TTM)

Not enough history to compute a Z-score for this multiple (3y · n=0).

EV / Sales (TTM)

Not enough history to compute a Z-score for this multiple (3y · n=0).

Dividend yield (TTM)

Not enough history to compute a Z-score for this multiple (3y · n=0).

No peer set loaded for SRZN. Run the peers loader to populate the comparison.

Pro

Multiples

Valuation multiples and peer comparisons are included with Pro.

Upgrade to Pro